The Merck Serono division of Merck KGaA has launched a new corporate venture capital arm, Merck Serono Ventures, to give the company early visibility on emerging innovation in its parent's core area of focus. (BioWorld International) BioWorld International CorrespondentThe Merck Serono division of Merck KGaA has launched a new corporate venture capital arm, Merck Serono Ventures, to give the company early visibility on emerging innovation in its parent's core area of focus. Read More
